Industry7 min read
Bac Water vs Sterile Water vs Saline: What to Use
Three injectable waters look identical, behave differently. One is wrong for multi-dose peptide vials — and one is wrong for peptides entirely.
Peptide News & Analysis
FDA actions, trial readouts, vendor coverage and pricing reports — curated for peptide buyers and clinicians.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
Latest News
Industry8 min read
MariTide: Amgen's Monthly GLP-1 Shot Sets New Bar
Amgen's monthly MariTide hit 20% weight loss at 52 weeks in Phase 2 with no plateau. Phase 3 readouts in 2027. Here is what it means for buyers.
Industry9 min read
How Long Is Bac Water Good For? Signs It's Gone Bad
28 days once opened and refrigerated — but three things shorten that. How to tell if a vial has gone bad, and what unopened shelf life really means.
Industry4 min read
Wegovy Pill Crushes Foundayo: 5x More Prescriptions
Novo's Q1 earnings show oral Wegovy hit 1M patients while Lilly's Foundayo logged just 3,707 scripts in week 2. What this means for buyers.
Trials8 min read
Retatrutide TRIUMPH-1: Q2 Readout Anchors NDA
Lilly's TRIUMPH-1 obesity readout drops Q2 2026 — the 80-week data that anchors retatrutide's NDA. What to expect, dose, and where to source.
Vendors8 min read
Nura Peptide Review: 30% Off Coupon
Nura Peptide: capsule peptides, pre-mixed nasal sprays, and a Reta+Cag combo. 30% off with thepeptidecatalog. Real pricing breakdown inside.
Pricing8 min read
Zepbound KwikPen at Retail: $299/mo Self-Pay
Branded tirzepatide is now $299/mo at Kroger, Publix, and Amazon Pharmacy. Here is how it compares to compounded research peptide pricing.
Industry6 min read
Semaglutide 7.2 mg Hits US: 20.7% Weight Loss
The new high-dose 7.2 mg pen is shipping after FDA priority approval. STEP UP hit 20.7% mean loss — what it means for research peptide buyers.
Industry6 min read
Semaglutide Cuts Heavy Drinking 41%: Lancet AUD Trial
Lancet phase 2b: 2.4 mg semaglutide cut heavy drinking days 41% in 26 weeks. What the data means for buyers, dose, and where to source.
Industry11 min read
$30 vs $300 Semaglutide: Where the Money Goes
Same Chinese factories, 10x price gap. We break down every dollar of compounded GLP-1 markup — what's real safety value vs telehealth marketing.
Industry8 min read
Ozempic Pill Launches in US: New Dose Strengths
Novo Nordisk's reformulated Ozempic tablets (1.5, 4, 9 mg) hit US pharmacies May 4. What changed, the new prices, and where compounded still wins.
Trials7 min read
Survodutide Phase 3: 16.6% Weight Loss in SYNCHRONIZE-1
Boehringer's GLP-1/glucagon dual agonist hit 16.6% weight loss at 76 weeks — comparable to semaglutide, short of tirzepatide. What it means for buyers.
Industry7 min read
Medicaid GLP-1 Coverage Starts May 1: BALANCE Model Live
CMS launched BALANCE Medicaid GLP-1 coverage May 1 — but Part D was just delayed. What it means for branded vs compounded buyers right now.
Regulatory5 min read
Ex-FDA Officials Push Back on RFK Peptide Reversal
Three former FDA officials say RFK Jr. mischaracterized their 2023 peptide-safety work. What the pushback means for buyers before the July 23 PCAC vote.
Regulatory8 min read
FDA Targets 503B GLP-1 Compounding: What Now
FDA proposed April 30 to bar 503B compounding of semaglutide, tirzepatide, and liraglutide. The comment window closed July 30. What survives the rule.
Trials6 min read
Eloralintide: Lilly Amylin Drug Hits 20% Weight Loss
Lilly's eloralintide hit 20% weight loss at 48 weeks in Phase 2 — without GLP-1. Here's what the amylin-only data means for obesity drugs.
Trials9 min read
Pfizer's Monthly GLP-1 Shot PF-3944: Phase 2b Results
Pfizer's once-monthly GLP-1 shot PF-3944 hit 12.3% placebo-adjusted weight loss in phase 2b. 10 phase 3 trials launching. Here is what it means.
Pricing7 min read
Oral Semaglutide Pill Price Hike: $199-$299 Now
GoodRx ended $149 introductory pricing on April 15. The 4 mg pill jumps to $199, the 9 mg and 25 mg pills to $299. Here is what to do about it.